View Single Post
Old 10-28-2022, 05:24 AM   #1
News
Senior Member
 
News's Avatar
 
Join Date: Oct 2007
Posts: 18,992
AKT inhibitor shows promise in a trial matching new treatments to cancer patients bas

In a trial matching new treatments to cancer patients based on the genetic make-up of their tumors, 22% of the patients treated with the AKT inhibitor drug ipatasertib had their tumors shrink.

More...
News is offline   Reply With Quote